529 related articles for article (PubMed ID: 34581996)
1. A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system.
Williams A; Branscome H; Khatkar P; Mensah GA; Al Sharif S; Pinto DO; DeMarino C; Kashanchi F
J Neurovirol; 2021 Oct; 27(5):667-690. PubMed ID: 34581996
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
[TBL] [Abstract][Full Text] [Related]
3. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
4. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism.
Karuppan MKM; Devadoss D; Nair M; Chand HS; Lakshmana MK
Mol Neurobiol; 2021 Jun; 58(6):2465-2480. PubMed ID: 33439437
[TBL] [Abstract][Full Text] [Related]
6. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.
Khan M; Khan H; Khan S; Nawaz M
J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802
[No Abstract] [Full Text] [Related]
8. The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis-A Preliminary Report.
Satheesh NJ; Salloum-Asfar S; Abdulla SA
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696521
[TBL] [Abstract][Full Text] [Related]
9. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
Murta V; Villarreal A; Ramos AJ
ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
Front Immunol; 2022; 13():888897. PubMed ID: 35663932
[TBL] [Abstract][Full Text] [Related]
11. Manifestations and mechanisms of central nervous system damage caused by SARS-CoV-2.
Yang F; Zhao H; Liu H; Wu X; Li Y
Brain Res Bull; 2021 Dec; 177():155-163. PubMed ID: 34571039
[TBL] [Abstract][Full Text] [Related]
12. Central nervous system outcomes of COVID-19.
Doyle MF
Transl Res; 2022 Mar; 241():41-51. PubMed ID: 34601116
[TBL] [Abstract][Full Text] [Related]
13. Neurological consequences of COVID-19.
Brola W; Wilski M
Pharmacol Rep; 2022 Dec; 74(6):1208-1222. PubMed ID: 36180640
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets.
Vallamkondu J; John A; Wani WY; Ramadevi SP; Jella KK; Reddy PH; Kandimalla R
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165889. PubMed ID: 32603829
[TBL] [Abstract][Full Text] [Related]
15. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.
Gulati A; Pomeranz C; Qamar Z; Thomas S; Frisch D; George G; Summer R; DeSimone J; Sundaram B
Am J Med Sci; 2020 Jul; 360(1):5-34. PubMed ID: 32620220
[TBL] [Abstract][Full Text] [Related]
16. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies.
Li CX; Noreen S; Zhang LX; Saeed M; Wu PF; Ijaz M; Dai DF; Maqbool I; Madni A; Akram F; Naveed M; Li JH
Biomed Pharmacother; 2022 Feb; 146():112550. PubMed ID: 34959116
[TBL] [Abstract][Full Text] [Related]
17. Potential neuroinvasive pathways of SARS-CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19).
Baig AM; Sanders EC
J Med Virol; 2020 Oct; 92(10):1845-1857. PubMed ID: 32492193
[TBL] [Abstract][Full Text] [Related]
18. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
Sharma A; Tiwari S; Deb MK; Marty JL
Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
[TBL] [Abstract][Full Text] [Related]
19. Neurological manifestations and comorbidity associated with COVID-19: an overview.
Kumar M; Thakur AK
Neurol Sci; 2020 Dec; 41(12):3409-3418. PubMed ID: 33052573
[TBL] [Abstract][Full Text] [Related]
20. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
Xu Y; Baylink DJ; Chen CS; Reeves ME; Xiao J; Lacy C; Lau E; Cao H
J Transl Med; 2020 Aug; 18(1):322. PubMed ID: 32847594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
